Yamada Eijiro, Bastie Claire C
Diabetes Research and Training Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America ; Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York, United States of America ; Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan.
Diabetes Research and Training Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, United States of America ; Division Metabolic and Vascular Health, Warwick Medical School, University of Warwick, Coventry, United Kingdom.
PLoS One. 2014 Feb 25;9(2):e89604. doi: 10.1371/journal.pone.0089604. eCollection 2014.
Fyn-deficient mice display increased AMP-activated Protein Kinase (AMPK) activity as a result of Fyn-dependent regulation of Liver Kinase B1 (LKB1) in skeletal muscle. Mutation of Fyn-specific tyrosine sites in LKB1 results in LKB1 export into the cytoplasm and increased AMPK activation site phosphorylation. This study characterizes the structural elements responsible for the physical interaction between Fyn and LKB1. Effects of point mutations in the Fyn SH2/SH3 domains and in the LKB1 proline-rich motif on 1) Fyn and LKB1 binding, 2) LKB1 subcellular localization and 3) AMPK phosphorylation were investigated in C2C12 muscle cells. Additionally, novel LKB1 proline-rich motif mimicking cell permeable peptides were generated to disrupt Fyn/LKB1 binding and investigate the consequences on AMPK activity in both C2C12 cells and mouse skeletal muscle. Mutation of either Fyn SH3 domain or the proline-rich motif of LKB1 resulted in the disruption of Fyn/LKB1 binding, re-localization of 70% of LKB1 signal in the cytoplasm and a 2-fold increase in AMPK phosphorylation. In vivo disruption of the Fyn/LKB1 interaction using LKB1 proline-rich motif mimicking cell permeable peptides recapitulated Fyn pharmacological inhibition. We have pinpointed the structural elements within Fyn and LKB1 that are responsible for their binding, demonstrating the functionality of this interaction in regulating AMPK activity.
由于Fyn对骨骼肌中肝脏激酶B1(LKB1)的依赖性调节,Fyn缺陷小鼠表现出AMP激活的蛋白激酶(AMPK)活性增加。LKB1中Fyn特异性酪氨酸位点的突变导致LKB1输出到细胞质中,并增加AMPK激活位点的磷酸化。本研究对负责Fyn与LKB1之间物理相互作用的结构元件进行了表征。在C2C12肌肉细胞中研究了Fyn SH2/SH3结构域和LKB1富含脯氨酸基序中的点突变对1)Fyn与LKB1结合、2)LKB1亚细胞定位和3)AMPK磷酸化的影响。此外,还生成了新型的模仿细胞可渗透肽的LKB1富含脯氨酸基序,以破坏Fyn/LKB1结合,并研究其对C2C12细胞和小鼠骨骼肌中AMPK活性的影响。Fyn SH3结构域或LKB1富含脯氨酸基序的突变导致Fyn/LKB1结合的破坏、70%的LKB1信号重新定位到细胞质中以及AMPK磷酸化增加2倍。使用模仿细胞可渗透肽的LKB1富含脯氨酸基序在体内破坏Fyn/LKB1相互作用,重现了Fyn的药理学抑制作用。我们已经确定了Fyn和LKB1中负责它们结合的结构元件,证明了这种相互作用在调节AMPK活性中的功能。